1996
DOI: 10.1016/0166-6851(96)02681-3
|View full text |Cite
|
Sign up to set email alerts
|

A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
56
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 88 publications
(61 citation statements)
references
References 47 publications
5
56
0
Order By: Relevance
“…The neutralizing monoclonal antibodies 7D10 and C6B6, which were first used to identify p23, are directed at linear (QDKPAD) and conformational epitopes, respectively, in the C-terminal region of p23. 11 Sturbaum and others reported that 9 of 10 monoclonal antibodies generated against C. parvum p23 were reactive with the p23 antigen from three C. hominis isolates, confirming that for the most part p23 is antigenically conserved among isolates from both species. 17,45 However, the epitopes recognized by human serum antibodies to p23 remain to be determined.…”
Section: P23 Antibodies and Polymorphisms In Children With Cryptospormentioning
confidence: 78%
See 1 more Smart Citation
“…The neutralizing monoclonal antibodies 7D10 and C6B6, which were first used to identify p23, are directed at linear (QDKPAD) and conformational epitopes, respectively, in the C-terminal region of p23. 11 Sturbaum and others reported that 9 of 10 monoclonal antibodies generated against C. parvum p23 were reactive with the p23 antigen from three C. hominis isolates, confirming that for the most part p23 is antigenically conserved among isolates from both species. 17,45 However, the epitopes recognized by human serum antibodies to p23 remain to be determined.…”
Section: P23 Antibodies and Polymorphisms In Children With Cryptospormentioning
confidence: 78%
“…[11][12][13][14] Monoclonal and bovine colostral antibodies to p23 protect against Cryptosporidium parvum challenge in mice and calves, respectively. 11,12,[15][16][17][18] The p23 antigen induces serum, mucosal, humoral, and cell-mediated immune responses in experimentally infected or immunized animals, [19][20][21][22][23][24][25][26] and active immunization with DNA or peptide vaccines targeting p23 has been shown to confer varying degrees of protection in animal models. [27][28][29] The p23 antigen is one of the most immunodominant Cryptosporidium antigens and is consistently recognized by serum from actively infected or previously exposed humans.…”
Section: Introductionmentioning
confidence: 99%
“…Of the multiple antigens recognized by 3E2, CSL was shown to be the critical surface-exposed species mechanistically bound by MAb to elicit the CSP-like reaction (39). The neutralizing activity of MAb 3E2 in vitro and its ability to passively protect against infection in vivo (19, 39) are profoundly greater than those of other MAbs we have produced against C. parvum (31,33,37,38,42). Therefore, MAb 3E2 was deemed an essential formulation candidate in the present study.…”
mentioning
confidence: 91%
“…The C. parvum antigens GP25-200 (1,39), CSL (39,40), and P23 (1,23) were selected as targets for the present study. Each antigen is involved in the pathogenesis of infection, expressed on the surface of both infective zoite stages, and conserved on diverse C. parvum isolates (1,23,31,39,40). GP25-200 was originally defined by MAb C4A1 as a sporozoite apical and surface pellicle glycoprotein complex comprised of multiple 25-to 200-kDa species identified in reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (1).…”
mentioning
confidence: 99%
“…These proteins, as well as proteins on the surface of the zoite, facilitate attachment to the cell surface, gliding motility, and subsequent invasion and intracellular development of the parasite. However, unlike those of other apicomplexans, most of the Cryptosporidium surface and apical complex antigens that have been characterized are glycoproteins [9][10][11][12][13][14]. Two of these, gp900 [10] and gp40/15 [11,13,14], are mucin-like glycoproteins, proteins with high percentages of serine and threonine residues that are sites for O-linked glycosylation.…”
Section: Introductionmentioning
confidence: 99%